It has been more than twenty years since the collapse of the World Trade Center on September 11th, 2001. Dr. Slavin discusses Myriad Genetics’ company-wide involvement in the effort to help identify victims of the tragedy with John Ryan, Sr. VP of Operations, Women’s Health and Oncology, and Benoît Leclair, Program Director of Quality Assurance and Regulatory Affairs.

It has been more than twenty years since the collapse of the World Trade Center on September 11th, 2001. Dr. Slavin discusses Myriad Genetics’ company-wide involvement in the effort to help identify victims of the tragedy with John Ryan, Sr. VP of Operations, Women’s Health and Oncology, and Benoît Leclair, Program Director of Quality Assurance and Regulatory Affairs.

It has been more than twenty years since the collapse of the World Trade Center on September 11th, 2001. Dr. Slavin discusses Myriad Genetics’ company-wide involvement in the effort to help identify victims of the tragedy with John Ryan, Sr. VP of Operations, Women’s Health and Oncology, and Benoît Leclair, Program Director of Quality Assurance and Regulatory Affairs.&nbsp;

Remembering 911- A Genetics’ company’s response to the September 11th tragedy.

Hosted by Dr. Thomas Slavin, Chief Medical Officer for Myriad Genetics, Inside the GENOME will be exploring the world of cutting-edge cancer genetics with 2-3 episodes per month. Dr. Slavin will interview those on the front lines of cancer, and those advancing the science of cancer prevention, diagnosis, and treatment. Inside the GENOME - Genetics, Oncology and Me.

Share Remembering 911- A Genetics’ company’s response to the September 11th tragedy.

Sign up to save your podcasts

Remembering 911- A Genetics’ company’s response to the September 11th tragedy.

Remembering 911- A Genetics’ company’s response to the September 11th tragedy.